Toggle navigation
About
About The ASCO Post
Editorial Board
Rights and Permissions
Contact
Subscribe
News
FDA Update
Journal Spotlight
Expert's Corner
In the Clinic
View By Issue
View All
Meetings
ASCO Breakthrough 2026
ASCO 2026
ESTRO 2026
AACR 2026
EBCC15
Calendar
View All
Topics
AI in Oncology
Breast Cancer
Lung Cancer
Prostate Cancer
Lymphoma
Cardio-oncology
View All
Videos
Newsreels
Video Roundtables
Podcasts
Subscribe
Advertisement
Advertisement
Education in Oncology,Education in Oncology
Advertisement
Advertisement
Aug
06
Today In Oncology
Early Trial Supports KRAS Vaccine Strategy for Pancreatic Cancer Interception
All-Oral Combination of Revumenib, Decitabine/Cedazuridine, and Venetoclax for Relapsed or Refractory AML
New Data on 14- vs 28-Day Venetoclax/Azacitidine in AML
Fusobacterium Positivity Predicts Relapse Risk and Limited Benefit From Adjuvant Chemotherapy in Colorectal Cancer
Durvalumab Plus Radiation Therapy in Frail Patients With Locally Advanced NSCLC
View More
Advertisement
